We then assigned these samples to breast cancer molecular subtypes based on the PAM50 classification (Parker et al., 2009), with the TAM signature showing significantly higher expression in human epidermal growth factor receptor 2 (Her2) compared with luminal A or B samples (p = 0.02) (Figure 3B). The gene discussed is ERBB2; the disease is breast carcinoma.